Perfromance Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Perfromance Wealth Partners's AMGN Position: Q1 2026 in Review
Perfromance Wealth Partners increased its Amgen (AMGN) stake by 0.13% in Q1 2026, buying an estimated $1.43K and bringing the position to 3,003 shares worth $1.06M. The position accounts for 0.03% of the portfolio, ranked #83.
Perfromance Wealth Partners first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $8.61M in Q4 2023. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Perfromance Wealth Partners held 3,003 shares of Amgen worth $1.06M as of Q1 2026.
- Perfromance Wealth Partners bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
- Amgen made up 0.03% of Perfromance Wealth Partners's portfolio in Q1 2026, its #83 holding.
- Perfromance Wealth Partners first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
- Perfromance Wealth Partners's Amgen position peaked at $8.61M in Q4 2023.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.